LBA-007Updated results of TRIBE2, a phase III, randomized strategy study by GONO in the 1st- and 2nd-line treatment of unresectable mCRC. (2nd July 2019) - Cremolini, C; Antoniotti, C; Lonardi, S; Rossini, D; Morano, F; Cordio, S; Bergamo, F; Marmorino, F; Maiello, E; Passardi, A; Masi, G; Tamburini, E; et al.